New 3D bioprinting subsidiary launching to focus on kidney diseases

A newly launching subsidiary of Nano Dimension (Ness Ziona, Israel) will focus on solutions for end-stage renal disease. Nano Dimension (Ness Ziona, Israel) has announced that it will form a new subsidiary to develop a platform for 3D bioprinting of cells and tissues to form biological models of the human kidney. This model will be utilized to study end-stage renal disease, which leads to kidney failure. "We believe that our high-end 3D printing capabilities, together with our expertise in nanochemistry and advanced materials, provide significant added value to the promising field of bioprinting," commented Amit Dror, CEO of Nano Dimension....